The setup is compelling: rare public exposure to proliferated defense space plus a new medium-lift rocket. The catch is simple—execution must stay clean because the multiple leaves little room for slips.

If Rocket Lab converts today’s defense prime wins into repeatable constellation production while proving Neutron reliability, it can grow into a scarce “end-to-end” defense-space platform where revenue scale outruns multiple compression by 2031.

Geopolitics-driven demand for proliferated space systems rewards trusted, vertically integrated producers; Rocket Lab is positioned as a scarce public proxy, but not a core AI compute platform.

Rocket Lab’s upside is not just more launches; it’s compounding credibility into higher-dollar defense space production (satellites + payloads + subsystems), with launch as a pull-through and schedule-control lever. If Neutron becomes a credible medium-lift option, Rocket Lab expands into missions where reliability and integration matter more than the lowest price, supporting a durable premium versus traditional aerospace primes. The base risk is multiple compression from today’s high expectations, but 5-year revenue scale can still dominate if execution stays clean.

The dominant risk is an execution-to-valuation trap: the stock is priced like a scarce “SpaceX alternative + defense prime,” but Neutron is still a pre-flight asset and large fixed-price space systems programs can surprise on cost. Near-term credibility events (guidance, Neutron milestones) can move the multiple faster than fundamentals.

$77.13